Skip to main content
Sopharma Properties REIT logo

Sopharma Properties REIT — Investor Relations & Filings

Ticker · SFI ISIN · BG1100031068 LEI · 8945008OK90PXHE1RL82 BSOBGN Real estate activities
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFI

About Sopharma Properties REIT

https://sopharma-imoti.com/english-home/

Sopharma Properties REIT is a special purpose investment company that focuses on the securitization of real estate. The company's primary activity involves investing in the real estate sector by acquiring, developing, and constructing properties. These assets are primarily managed for rental and leasing purposes. The company also engages in the selling of properties and provides real estate management services on a fee basis. Its investment strategy includes purchasing titles and other rights over land and various real estate assets.

Recent filings

Filing Released Lang Actions
ДЕКЛАРАЦИЯ.pdf
Regulatory Filings Classification · 90% confidence The document is a declaration under Bulgarian securities law where the company’s executive director and chief accountant attest to the accuracy of the interim financial statements and interim activity report as of 31.03.2026. It contains no substantive financial data itself but serves as an officer certification letter. Under the CERTIFICATION RULE, such attestations are classified as Regulatory Filings (RNS).
2026-04-29 Bulgarian
Q1 2026.pdf
Interim / Quarterly Report Classification · 92% confidence The document is titled “Приложения към междинния финансов отчет за периода от 01.01.2026 г. до 31.03.2026 г.” (Appendices to the interim financial report for the period January 1 – March 31 2026). It contains actual financial statements (comprehensive income, financial position, cash flows, changes in equity) and detailed accounting policies and notes, indicating it is an interim/quarterly report rather than merely an announcement or a certification. Therefore, it should be classified as an Interim / Quarterly Report. Q1 2026
2026-04-29 Bulgarian
SFI_FS 2026 Q1.xlsx.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled “Междинен отчет” (“Interim Report”) and contains full interim financial statements (comprehensive income, financial position, cash flows, changes in equity) for the three-month period ended 31 March 2026, with detailed notes and digital signatures. This is a substantive quarterly/interim report rather than an announcement or summary. Therefore it falls under Interim / Quarterly Report (IR). Q1 2026
2026-04-29 Bulgarian
Чл.pdf
Regulatory Filings Classification · 42% confidence The document is titled “Допълнителна информация към междинен финансов отчет… към 31.03.2026” and contains regulatory disclosures (accounting policy changes, shareholdings, legal proceedings, loans) required under Bulgarian Commission for Financial Supervision rules. It does not include actual interim financial statements or management discussion of financial results, nor is it merely an announcement that a report is available. It is a compliance filing providing additional information to an interim report. This falls under General Regulatory Filings (RNS) as a miscellaneous regulatory submission rather than a standalone interim report or announcement.
2026-04-29 Bulgarian
ДОПЪЛНИТЕЛНА ИНФОРМАЦИЯ ПО ЧЛ.pdf
Regulatory Filings Classification · 82% confidence The document is a statutory compliance statement under Bulgarian investment laws (ZDSICDS and related regulation) as of 31.03.2026, providing asset and investment breakdowns, compliance checks, and minimal numerical data. It is not a full financial report (no full financial statements), not an announcement of a report availability, nor a specific filing like AGM materials, earnings release, interim report, or ESG report. Therefore, it falls under the fallback category for miscellaneous regulatory filings.
2026-04-29 Bulgarian
„СОФАРМА ИМОТИ” АДСИЦ.pdf
Regulatory Filings Classification · 93% confidence The document is an “Appendix No. 4” to Art. 12 of the Bulgarian FSC Regulation No. 2/2021, covering corporate events (shareholders, insolvency, material transactions, audits, legal proceedings) for Q1 2026. There are no actual financial statements or substantive financial analysis—only regulatory disclosures and a note that the interim financial report is published elsewhere. It is a compliance/regulatory filing rather than the full interim/quarterly report. Thus, it falls under the fallback Regulatory Filings category (RNS).
2026-04-29 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.